FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:640-649 August 29, 1996 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

Uterine cancer is the fourth most frequent cancer in women, with an estimated 34,000 cases and 6000 deaths in the United States in 1996.¹ It is the most curable of the 10 most common cancers in women and the most frequent and curable of the gynecologic cancers. Ninety-seven percent of all cancers of the uterus arise from the glands of the endometrium and are known as endometrial carcinomas. The remaining 3 percent of uterine cancers are sarcomas, which are not discussed here. Numerous changes in the pathological description of endometrial cancer, identification of prognostic variables, staging, and treatment have occurred . . . [Full Text of this Article]

Epidemiology and Pathogenesis

Environmental Factors

Familial and Genetic Factors

Diagnosis and Screening

Prognostic Factors

Clinical Characteristics

Biologic Markers

Treatment

Source Information

From the Division of Gynecologic Oncology, Department of Reproductive Biology, University Hospitals of Cleveland, and the Ireland Cancer Center, Case Western Reserve University, Cleveland.

Address reprint requests to Dr. Rose at the Division of Gynecologic Oncology, Department of Reproductive Biology, University Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44107.

References

Related Letters:

Endometrial Carcinoma
Lee J. R., Verhoeven A. T.M., Rose P. G.
Extract | Full Text  
N Engl J Med 1997; 336:1388-1389, May 8, 1997. Correspondence

This article has been cited by other articles:

• Graesslin, O., Chantot-Bastaraud, S., Lorenzato, M., Birembaut, P., Quereux, C., Darai, E. (2008). Fluorescence in situ Hybridization and Immunohistochemical Analysis of p53 Expression in Endometrial Cancer: Prognostic Value and Relation to Ploidy. Ann. Surg. Oncol. 15: 484-492 [Abstract] [Full Text]  
• Duncan, C., Powers, J., Davis, T., Spraker, T. (2007). Abomasal and uterine adenocarcinomas with ovarian metastasis in a captive elk (Cervus elaphus nelsoni). jvdi 19: 560-563 [Abstract] [Full Text]  
• Yang, J.-H., Wu, M.-Y., Chen, C.-D., Chen, M.-J., Yang, Y.-S., Ho, H.-N. (2007). Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod 22: 945-952 [Abstract] [Full Text]  
• Pijnenborg, J., Dam-de Veen, G., Kisters, N, Delvoux, B, van Engeland, M, Herman, J., Groothuis, P. (2007). RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer. Ann Oncol 18: 491-497 [Abstract] [Full Text]  
• Graesslin, O., Cortez, A., Fauvet, R., Lorenzato, M., Birembaut, P., Darai, E. (2006). Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol 17: 637-645 [Abstract] [Full Text]  
• Hammoud, A. O., Deppe, G., Elkhechen, S. S., Johnson, S. (2006). Ultrasonography-Guided Transvaginal Endometrial Biopsy: A Useful Technique in Patients With Cervical Stenosis. Obstet Gynecol 107: 518-520 [Abstract] [Full Text]  
• Albitar, L., Laidler, L. L., Abdallah, R., Leslie, K. K. (2005). Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors. Molecular Cancer Therapeutics 4: 1891-1899 [Abstract] [Full Text]  
• Saitoh, M., Ohmichi, M., Takahashi, K., Kawagoe, J., Ohta, T., Doshida, M., Takahashi, T., Igarashi, H., Mori-Abe, A., Du, B., Tsutsumi, S., Kurachi, H. (2005). Medroxyprogesterone Acetate Induces Cell Proliferation through Up-Regulation of Cyclin D1 Expression via Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor-{kappa}B Cascade in Human Breast Cancer Cells. Endocrinology 146: 4917-4925 [Abstract] [Full Text]  
• Goodman, A. (2005). Endometrial Cancer With Concurrent Ovarian Malignancy: Assessing the Risks. Obstet Gynecol 106: 680-681 [Full Text]  
• Kabir-Salmani, M., Shimizu, Y., Sakai, K., Iwashita, M. (2005). Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitro. Mol Hum Reprod 11: 667-671 [Abstract] [Full Text]  
• Smid-Koopman, E., Kuhne, L. C. M., Hanekamp, E. E., Gielen, S. C.J.P., De Ruiter, P. E., Grootegoed, J. A., Helmerhorst, T. J.M., Burger, C. W., Brinkmann, A. O., Huikeshoven, F. J., Blok, L. J. (2005). Progesterone-Induced Inhibition of Growth and Differential Regulation of Gene Expression in PRA- and/or PRB-Expressing Endometrial Cancer Cell Lines. Reproductive Sciences 12: 285-292 [Abstract]  
• Santin, A. D., Diamandis, E. P., Bellone, S., Soosaipillai, A., Cane, S., Palmieri, M., Burnett, A., Roman, J. J., Pecorelli, S. (2005). Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer. Clin. Cancer Res. 11: 3320-3325 [Abstract] [Full Text]  
• Althuis, M. D., Moghissi, K. S., Westhoff, C. L., Scoccia, B., Lamb, E. J., Lubin, J. H., Brinton, L. A. (2005). Uterine Cancer after Use of Clomiphene Citrate to Induce Ovulation. Am J Epidemiol 161: 607-615 [Abstract] [Full Text]  
• Blauer, M., Heinonen, P.K., Martikainen, P.M., Tomas, E., Ylikomi, T. (2005). A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate. Hum Reprod 20: 864-871 [Abstract] [Full Text]  
• Gielen, S. C.J.P., Hanekamp, E. E., Blok, L. J., Huikeshoven, F. J., Burger, C. W. (2005). Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling?. Reproductive Sciences 12: 58-64 [Abstract]  
• Dai, D., Albitar, L., Nguyen, T., Laidler, L. L., Singh, M., Leslie, K. K. (2005). A therapeutic model for advanced endometrial cancer: Systemic progestin in combination with local adenoviral-mediated progesterone receptor expression. Molecular Cancer Therapeutics 4: 169-175 [Abstract] [Full Text]  
• Planaguma, J., Diaz-Fuertes, M., Gil-Moreno, A., Abal, M., Monge, M., Garcia, A., Baro, T., Thomson, T. M., Xercavins, J., Alameda, F., Reventos, J. (2004). A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma. Cancer Res. 64: 8846-8853 [Abstract] [Full Text]  
• Madison, T., Schottenfeld, D., James, S. A., Schwartz, A. G., Gruber, S. B. (2004). Endometrial Cancer: Socioeconomic Status and Racial/Ethnic Differences in Stage at Diagnosis, Treatment, and Survival. Am. J. Public Health 94: 2104-2111 [Abstract] [Full Text]  
• Holland, C. M., Saidi, S. A., Evans, A. L., Sharkey, A. M., Latimer, J. A., Crawford, R. A.F., Charnock-Jones, D. S., Print, C. G., Smith, S. K. (2004). Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets. Molecular Cancer Therapeutics 3: 993-1001 [Abstract] [Full Text]  
• Manfredi, R., Mirk, P., Maresca, G., Margariti, P. A., Testa, A., Zannoni, G. F., Giordano, D., Scambia, G., Marano, P. (2004). Local-Regional Staging of Endometrial Carcinoma: Role of MR Imaging in Surgical Planning. Radiology 231: 372-378 [Abstract] [Full Text]  
• Arnett-Mansfield, R. L., deFazio, A., Mote, P. A., Clarke, C. L. (2004). Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium. J. Clin. Endocrinol. Metab. 89: 1429-1442 [Abstract] [Full Text]  
• Petridou, E., Mantzoros, C., Dessypris, N., Koukoulomatis, P., Addy, C., Voulgaris, Z., Chrousos, G., Trichopoulos, D. (2003). Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece. J. Clin. Endocrinol. Metab. 88: 993-997 [Abstract] [Full Text]  
• Szklaruk, J., Tamm, E. P., Choi, H., Varavithya, V. (2003). MR Imaging of Common and Uncommon Large Pelvic Masses. RadioGraphics 23: 403-424 [Abstract] [Full Text]  
• Kaaks, R., Lukanova, A., Kurzer, M. S. (2002). Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review. Cancer Epidemiol. Biomarkers Prev. 11: 1531-1543 [Abstract] [Full Text]  
• Musgrove, E. A., Hunter, L.-J. K., Lee, C. S. L., Swarbrick, A., Hui, R., Sutherland, R. L. (2001). Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2. J. Biol. Chem. 276: 47675-47683 [Abstract] [Full Text]  
• Mote, P A, Johnston, J F, Manninen, T, Tuohimaa, P, Clarke, C L (2001). Detection of progesterone receptor forms A and B by immunohistochemical analysis. J. Clin. Pathol. 54: 624-630 [Abstract] [Full Text]  
• Arnett-Mansfield, R. L., deFazio, A., Wain, G. V., Jaworski, R. C., Byth, K., Mote, P. A., Clarke, C. L. (2001). Relative Expression of Progesterone Receptors A and B in Endometrioid Cancers of the Endometrium. Cancer Res. 61: 4576-4582 [Abstract] [Full Text]  
• Fiumicino, S., Ercoli, A., Ferrandina, G., Hess, P., Raspaglio, G., Genuardi, M., Rovella, V., Bellacosa, A., Cicchillitti, L., Mancuso, S., Bignami, M., Scambia, G. (2001). Microsatellite Instability Is an Independent Indicator of Recurrence in Sporadic Stage I-II Endometrial Adenocarcinoma. JCO 19: 1008-1014 [Abstract] [Full Text]  
• Bermont, L., Lamielle, F., Lorchel, F., Fauconnet, S., Esumi, H., Weisz, A., Adessi, G. L. (2001). Insulin Up-Regulates Vascular Endothelial Growth Factor and Stabilizes Its Messengers in Endometrial Adenocarcinoma Cells. J. Clin. Endocrinol. Metab. 86: 363-368 [Abstract] [Full Text]  
• LAVIE, O., HORNREICH, G., BEN ARIE, A., RENBAUM, P., LEVY-LAHAD, E., BELLER, U. (2000). BRCA1 Germline Mutations in Women With Uterine Serous Papillary Carcinoma. Obstet Gynecol 96: 28-32 [Abstract] [Full Text]  
• Salvesen, H. B., Das, S., Akslen, L. A. (2000). Loss of Nuclear p16 Protein Expression Is Not Associated with Promoter Methylation but Defines a Subgroup of Aggressive Endometrial Carcinomas with Poor Prognosis. Clin. Cancer Res. 6: 153-159 [Abstract] [Full Text]  
• Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., Vogel, V. (1999). Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer. JNCI J Natl Cancer Inst 91: 1829-1846 [Abstract] [Full Text]  
• Xu, X., Duncan, A. M., Merz-Demlow, B. E., Phipps, W. R., Kurzer, M. S. (1999). Menstrual Cycle Effects on Urinary Estrogen Metabolites. J. Clin. Endocrinol. Metab. 84: 3914-3918 [Abstract] [Full Text]  
• Outwater, E. K. (1999). Invited Commentary. RadioGraphics 19: 946-947 [Full Text]  
• Salvesen, H. B., Iversen, O. E., Akslen, L. A. (1999). Prognostic Significance of Angiogenesis and Ki-67, p53, and p21 Expression: A Population-Based Endometrial Carcinoma Study. JCO 17: 1382-1382 [Abstract] [Full Text]  
• Smith-Bindman, R., Kerlikowske, K., Feldstein, V. A., Subak, L., Scheidler, J., Segal, M., Brand, R., Grady, D. (1998). Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities. JAMA 280: 1510-1517 [Abstract] [Full Text]  
• Swisher, E. M., Mutch, D. G., Herzog, T. J., Rader, J. S., Kowalski, L. D., Elbendary, A., Goodfellow, P. J. (1998). Analysis of MSH3 in Endometrial Cancers With Defective DNA Mismatch Repair. Reproductive Sciences 5: 210-216 [Abstract]  
• Musgrove, E. A., Swarbrick, A., Lee, C. S. L., Cornish, A. L., Sutherland, R. L. (1998). Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins. Mol. Cell. Biol. 18: 1812-1825 [Abstract] [Full Text]  
• Langer, R. D., Pierce, J. J., O'Hanlan, K. A., Johnson, S. R., Espeland, M. A., Trabal, J. F., Barnabei, V. M., Merino, M. J., Scully, R. E., The Postmenopausal Estrogen/Progestin Intervention, (1997). Transvaginal Ultrasonography Compared with Endometrial Biopsy for the Detection of Endometrial Disease. NEJM 337: 1792-1798 [Abstract] [Full Text]  
• Lee, J. R., Verhoeven, A. T.M., Rose, P. G. (1997). Endometrial Carcinoma. NEJM 336: 1388-1389 [Full Text]